Inventor claims bleach injections will destroy cancer tumors

Inventor claims bleach injections will destroy cancer tumors

Xuewu Liu, an inventor from China without any formal medical training, is offering a controversial treatment for cancer patients at a steep price of $20,000. This method involves injecting a concentrated solution of chlorine dioxide—a toxic bleach—directly into tumors, and it is being promoted as an AI-driven solution, despite lacking scientific validation. One patient who underwent this procedure reported that her tumor has accelerated in growth since the injections, raising concerns that the treatment may have contributed to the spread of her cancer. Liu, however, challenges this assertion. Medical experts warn that his promotional tactics could place him in violation of U.S. regulations regarding medical treatments. Currently, Liu's treatment is available informally in China and at a clinic in Germany. However, he is collaborating with a former pharmaceutical executive based in Texas to introduce this untested method to the U.S. market. They are optimistic that the appointment of Robert F. Kennedy Jr. as U.S. health secretary will facilitate the approval process for their therapy, which has garnered interest from at least one clinic in California. Kennedy's initiative, known as Make America Healthy Again, is promoting alternative medicine and patient autonomy in exploring unproven treatments. Although Kennedy has not commented specifically on Liu's method, he has previously mentioned chlorine dioxide in the context of health discussions. Interestingly, the Food and Drug Administration (FDA) recently archived a warning related to chlorine dioxide, a move that some interpret as a potential opening for therapies involving this substance. Liu believes that the FDA's decision to remove its warnings could have significant implications for his treatment's acceptance in clinical trials and funding opportunities. He expressed his hopes in a letter to Kennedy, urging for further investigation into chlorine dioxide. "This subtle change may not lead to immediate results, but it certainly paves the way for renewed interest in serious research on chlorine dioxide," Liu stated.

Sources : Ars Technica

Published On : Jul 25, 2025, 15:35

AI
Navigating the Ethical Maze of AI: A Controversial Perspective

A provocative question arises: Should AI be developed to assist individuals in harmful actions, such as plotting a crime...

TechCrunch | Jul 13, 2026, 16:45
Navigating the Ethical Maze of AI: A Controversial Perspective
Startups
Wall Street's Renewed Confidence Powers Tech Stock Surge

A prominent technology stock has received a significant lift from Wall Street analysts, reflecting growing optimism abou...

CNBC | Jul 13, 2026, 16:05
Wall Street's Renewed Confidence Powers Tech Stock Surge
Automotive
Uber and Waymo Clash Over Future of Autonomous Vehicle Regulations

A new legislative proposal in Washington, D.C. has sparked a significant debate between Uber and Waymo over the future o...

TechCrunch | Jul 13, 2026, 12:55
Uber and Waymo Clash Over Future of Autonomous Vehicle Regulations
Startups
General Fusion Makes Historic Nasdaq Debut as First Publicly Traded Fusion Company

General Fusion has officially commenced trading on the Nasdaq under the ticker symbol GFUZ, marking a significant milest...

TechCrunch | Jul 13, 2026, 17:25
General Fusion Makes Historic Nasdaq Debut as First Publicly Traded Fusion Company
Aerospace
SpaceX Set for Starship's Comeback Launch with Enhanced Features

SpaceX has received the green light from the Federal Aviation Administration (FAA) to resume flights of its Starship pro...

TechCrunch | Jul 13, 2026, 14:30
SpaceX Set for Starship's Comeback Launch with Enhanced Features
View All News